These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20872081)

  • 1. Translocator protein PET imaging for glial activation in multiple sclerosis.
    Oh U; Fujita M; Ikonomidou VN; Evangelou IE; Matsuura E; Harberts E; Fujimura Y; Richert ND; Ohayon J; Pike VW; Zhang Y; Zoghbi SS; Innis RB; Jacobson S
    J Neuroimmune Pharmacol; 2011 Sep; 6(3):354-61. PubMed ID: 20872081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients.
    Harberts E; Datta D; Chen S; Wohler JE; Oh U; Jacobson S
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):51-7. PubMed ID: 22956240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [
    Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; ; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
    Mol Psychiatry; 2017 Jun; 22(6):850-856. PubMed ID: 28194003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Herranz E; Treaba CA; Barletta VT; Mehndiratta A; Ouellette R; Sloane JA; Ionete C; Babu S; Mastantuono M; Magon S; Loggia ML; Makary MM; Hooker JM; Catana C; Kinkel RP; Nicholas R; Klawiter EC; Magliozzi R; Mainero C
    Brain; 2024 Jul; 147(7):2566-2578. PubMed ID: 38289855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.
    Datta G; Violante IR; Scott G; Zimmerman K; Santos-Ribeiro A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Matthews PM
    Mult Scler; 2017 Oct; 23(11):1469-1478. PubMed ID: 27903933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy and reliability of [
    Plavén-Sigray P; Schain M; Zanderigo F; ; Rabiner EA; Gunn RN; Ogden RT; Cervenka S
    Neuroimage; 2019 Mar; 188():102-110. PubMed ID: 30500425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.
    Albrecht DS; Forsberg A; Sandström A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Höglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
    Brain Behav Immun; 2019 Jan; 75():72-83. PubMed ID: 30223011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
    Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
    J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
    Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
    Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
    Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N
    Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
    Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
    J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
    Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; Reynolds R; Matthews PM; Parker CA
    J Nucl Med; 2011 Jan; 52(1):24-32. PubMed ID: 21149489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker.
    Kreisl WC; Fujita M; Fujimura Y; Kimura N; Jenko KJ; Kannan P; Hong J; Morse CL; Zoghbi SS; Gladding RL; Jacobson S; Oh U; Pike VW; Innis RB
    Neuroimage; 2010 Feb; 49(4):2924-32. PubMed ID: 19948230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
    Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
    J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.
    Narendran R; Lopresti BJ; Mason NS; Deuitch L; Paris J; Himes ML; Kodavali CV; Nimgaonkar VL
    J Neurosci; 2014 Jul; 34(30):9945-50. PubMed ID: 25057196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.